GemPharmatech Statistics

Total Valuation

GemPharmatech has a market cap or net worth of CNY 8.47 billion. The enterprise value is 7.62 billion.

Market Cap	8.47B
Enterprise Value	7.62B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

GemPharmatech has 410.00 million shares outstanding. The number of shares has decreased by -2.43% in one year.

Current Share Class	410.00M
Shares Outstanding	410.00M
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	-4.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	17.81%
Float	166.26M

Valuation Ratios

The trailing PE ratio is 51.55 and the forward PE ratio is 44.91.

PE Ratio	51.55
Forward PE	44.91
PS Ratio	10.20
PB Ratio	3.72
P/TBV Ratio	3.84
P/FCF Ratio	52.49
P/OCF Ratio	33.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.42, with an EV/FCF ratio of 47.22.

EV / Earnings	47.70
EV / Sales	9.17
EV / EBITDA	27.42
EV / EBIT	37.91
EV / FCF	47.22

Financial Position

The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.10.

Current Ratio	3.58
Quick Ratio	3.17
Debt / Equity	0.10
Debt / EBITDA	0.85
Debt / FCF	1.46
Interest Coverage	329.45

Financial Efficiency

Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 12.65%.

Return on Equity (ROE)	7.20%
Return on Assets (ROA)	4.55%
Return on Invested Capital (ROIC)	12.65%
Return on Capital Employed (ROCE)	8.41%
Weighted Average Cost of Capital (WACC)	7.84%
Revenue Per Employee	526,369
Profits Per Employee	101,242
Employee Count	1,578
Asset Turnover	0.30
Inventory Turnover	4.07

Taxes

In the past 12 months, GemPharmatech has paid 28.04 million in taxes.

Income Tax	28.04M
Effective Tax Rate	14.93%

Stock Price Statistics

The stock price has increased by +81.71% in the last 52 weeks. The beta is 0.69, so GemPharmatech's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+81.71%
50-Day Moving Average	16.67
200-Day Moving Average	16.94
Relative Strength Index (RSI)	72.78
Average Volume (20 Days)	9,971,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GemPharmatech had revenue of CNY 830.61 million and earned 159.76 million in profits. Earnings per share was 0.40.

Revenue	830.61M
Gross Profit	534.53M
Operating Income	201.00M
Pretax Income	187.80M
Net Income	159.76M
EBITDA	276.71M
EBIT	201.00M
Earnings Per Share (EPS)	0.40

Full Income Statement

Balance Sheet

The company has 1.09 billion in cash and 235.14 million in debt, giving a net cash position of 850.49 million or 2.07 per share.

Cash & Cash Equivalents	1.09B
Total Debt	235.14M
Net Cash	850.49M
Net Cash Per Share	2.07
Equity (Book Value)	2.28B
Book Value Per Share	5.81
Working Capital	1.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 249.66 million and capital expenditures -88.28 million, giving a free cash flow of 161.38 million.

Operating Cash Flow	249.66M
Capital Expenditures	-88.28M
Depreciation & Amortization	75.71M
Net Borrowing	18.57M
Free Cash Flow	161.38M
FCF Per Share	0.39

Full Cash Flow Statement

Margins

Gross margin is 64.35%, with operating and profit margins of 24.20% and 19.23%.

Gross Margin	64.35%
Operating Margin	24.20%
Pretax Margin	22.61%
Profit Margin	19.23%
EBITDA Margin	33.31%
EBIT Margin	24.20%
FCF Margin	19.43%

Dividends & Yields

This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 0.68%.

Dividend Per Share	0.14
Dividend Yield	0.68%
Dividend Growth (YoY)	-26.32%
Years of Dividend Growth	n/a
Payout Ratio	38.16%
Buyback Yield	2.43%
Shareholder Yield	3.15%
Earnings Yield	1.89%
FCF Yield	1.91%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6